Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Dexmedetomidine hydrochloride Microneedles

Phase 2Small molecule

GGuangzhou Novaken Pharm Co., Ltd.

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Sedation1 trial

The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children

Recruiting·GGuangzhou Novaken Pharm Co., Ltd.·Phase 2·NCT07168720·64 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dexmedetomidine hydrochloride Microneedles. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexmedetomidine hydrochloride Microneedles compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexmedetomidine hydrochloride Microneedles. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Guangzhou Novaken Pharm Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: GGuangzhou Novaken Pharm Co., Ltd.

Related News